| 1 |
35174550 | Maltol mitigates cisplatin-evoked cardiotoxicity via inhibiting the PI3K/Akt signaling pathway in rodents in vivo and in vitro. | 2022 Apr |
1 |
| 2 |
35210433 | c-Myb protects cochlear hair cells from cisplatin-induced damage via the PI3K/Akt signaling pathway. | 2022 Feb 24 |
2 |
| 3 |
35236823 | Extracellular ATP promotes breast cancer chemoresistance via HIF-1α signaling. | 2022 Mar 2 |
1 |
| 4 |
35281608 | Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells In Vitro and In Vivo through Inhibiting the PI3K/AKT/mTOR/NF-κB Signaling Pathway. | 2022 |
3 |
| 5 |
35530288 | β-elemene suppresses tumor metabolism and stem cell-like properties of non-small cell lung cancer cells by regulating PI3K/AKT/mTOR signaling. | 2022 |
1 |
| 6 |
35548339 | Phenethylisothiocyanate Potentiates Platinum Therapy by Reversing Cisplatin Resistance in Cervical Cancer. | 2022 |
1 |
| 7 |
34077275 | Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity via modulating the PTEN-PI3K-AKT axis. | 2021 Jun |
1 |
| 8 |
34268902 | Exogenous insulin-like growth factor 1 attenuates cisplatin-induced muscle atrophy in mice. | 2021 Dec |
3 |
| 9 |
34381726 | TPL Inhibits the Invasion and Migration of Drug-Resistant Ovarian Cancer by Targeting the PI3K/AKT/NF-κB-Signaling Pathway to Inhibit the Polarization of M2 TAMs. | 2021 |
2 |
| 10 |
34461812 | Protective Effect of 20(R)-Ginsenoside Rg3 Against Cisplatin-Induced Renal Toxicity via PI3K/AKT and NF-[Formula: see text]B Signaling Pathways Based on the Premise of Ensuring Anticancer Effect. | 2021 |
1 |
| 11 |
34580062 | A PLCB1-PI3K-AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression. | 2021 Dec 1 |
1 |
| 12 |
34671212 | Long non-coding RNA MEG3 promotes cisplatin-induced nephrotoxicity through regulating AKT/TSC/mTOR-mediated autophagy. | 2021 |
2 |
| 13 |
31961716 | Inhibition of PDE4/PDE4B improves renal function and ameliorates inflammation in cisplatin-induced acute kidney injury. | 2020 Mar 1 |
1 |
| 14 |
32039764 | Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling. | 2020 Feb |
1 |
| 15 |
32150448 | Canagliflozin reduces cisplatin uptake and activates Akt to protect against cisplatin-induced nephrotoxicity. | 2020 Apr 1 |
1 |
| 16 |
32252554 | Cucurbitacin B and cisplatin induce the cell death pathways in MB49 mouse bladder cancer model. | 2020 May |
1 |
| 17 |
32280245 | The Metastasis Potential Promoting Capacity of Cancer-Associated Fibroblasts Was Attenuated by Cisplatin via Modulating KRT8. | 2020 |
3 |
| 18 |
33227065 | AKT isoforms have discrete expression in triple negative breast cancers and roles in cisplatin sensitivity. | 2020 Nov 10 |
4 |
| 19 |
33272245 | MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway. | 2020 Dec 3 |
1 |
| 20 |
33390985 | Linalool Prevents Cisplatin Induced Muscle Atrophy by Regulating IGF-1/Akt/FoxO Pathway. | 2020 |
1 |
| 21 |
30387162 | TLR2 protects cisplatin-induced acute kidney injury associated with autophagy via PI3K/Akt signaling pathway. | 2019 Mar |
4 |
| 22 |
30975980 | Akt inhibitor SC66 promotes cell sensitivity to cisplatin in chemoresistant ovarian cancer cells through inhibition of COL11A1 expression. | 2019 Apr 11 |
1 |
| 23 |
31320816 | Squalene attenuates the oxidative stress and activates AKT/mTOR pathway against cisplatin-induced kidney damage in mice. | 2019 |
2 |
| 24 |
31781349 | Remote Ischemic Preconditioning Protects Cisplatin-Induced Acute Kidney Injury through the PTEN/AKT Signaling Pathway. | 2019 |
1 |
| 25 |
29110119 | Metformin synergistically enhances antitumor activity of cisplatin in gallbladder cancer via the PI3K/AKT/ERK pathway. | 2018 Feb |
1 |
| 26 |
29284644 | COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. | 2018 Feb |
1 |
| 27 |
29556279 | HSPA12B overexpression induces cisplatin resistance in non-small-cell lung cancer by regulating the PI3K/Akt/NF-κB signaling pathway. | 2018 Mar |
1 |
| 28 |
30121639 | High Platelet Levels Attenuate the Efficacy of Platinum-Based Treatment in Non-Small Cell Lung Cancer. | 2018 |
2 |
| 29 |
30235825 | Platycodon grandiflorum Saponins Ameliorate Cisplatin-Induced Acute Nephrotoxicity through the NF-κB-Mediated Inflammation and PI3K/Akt/Apoptosis Signaling Pathways. | 2018 Sep 19 |
1 |
| 30 |
30374107 | The protective effects of maltol on cisplatin-induced nephrotoxicity through the AMPK-mediated PI3K/Akt and p53 signaling pathways. | 2018 Oct 29 |
1 |
| 31 |
27799485 | Protein Kinase Cδ Suppresses Autophagy to Induce Kidney Cell Apoptosis in Cisplatin Nephrotoxicity. | 2017 Apr |
9 |
| 32 |
28255274 | Hyperhomocysteinemia Exacerbates Cisplatin-induced Acute Kidney Injury. | 2017 |
1 |
| 33 |
28762162 | Effect of acute treadmill exercise on cisplatin-induced muscle atrophy in the mouse. | 2017 Nov |
1 |
| 34 |
26882203 | Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN/AKT/FOXO3a pathway activation in the mouse ovary. | 2016 Apr |
3 |
| 35 |
27825756 | Carvacrol attenuates acute kidney injury induced by cisplatin through suppression of ERK and PI3K/Akt activation. | 2016 Dec |
1 |
| 36 |
27876874 | TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling. | 2016 Nov 23 |
3 |
| 37 |
25978595 | Liquiritigenin Potentiates the Inhibitory Effects of Cisplatin on Invasion and Metastasis Via Downregulation MMP-2/9 and PI3 K/AKT Signaling Pathway in B16F10 Melanoma Cells and Mice Model. | 2015 |
2 |
| 38 |
26136189 | Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved. | 2015 Jun |
1 |
| 39 |
26656301 | Cisplatin Induces Overactivation of the Dormant Primordial Follicle through PTEN/AKT/FOXO3a Pathway which Leads to Loss of Ovarian Reserve in Mice. | 2015 |
4 |
| 40 |
24823295 | Mechanisms of cisplatin-induced muscle atrophy. | 2014 Jul 15 |
2 |
| 41 |
25071019 | Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles. | 2014 Aug 15 |
1 |
| 42 |
25282897 | [Effect of Buzhong Yiqi decoction on PI3K and AKT in spleen, stomach and lung of nude mice with lung adenocarcinoma transplantation tumor]. | 2014 May |
5 |
| 43 |
23095324 | Molecular imaging reveals a role for AKT in resistance to cisplatin for ovarian endometrioid adenocarcinoma. | 2013 Jan 1 |
1 |
| 44 |
24130050 | Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinoma. | 2013 Dec |
3 |
| 45 |
22760211 | Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo. | 2012 Nov |
6 |
| 46 |
21074548 | Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems. | 2011 Feb 1 |
4 |
| 47 |
22096562 | The role of proline rich tyrosine kinase 2 (Pyk2) on cisplatin resistance in hepatocellular carcinoma. | 2011 |
2 |
| 48 |
20506484 | PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice. | 2010 Sep 1 |
1 |
| 49 |
18046317 | The phosphoinositide-3 kinase gamma-Akt pathway mediates renal tubular injury in cisplatin nephrotoxicity. | 2008 Feb |
2 |
| 50 |
18364504 | Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy. | 2008 Apr 2 |
1 |